Genome-wide association studies burst onto the scene in the mid-2000s, and they are showing their worth for predicting disease risk, classifying disease, and examining gene-drug interactions, writes Muin Khoury, the director of the public health genomics office at the US Centers for Disease Control and Prevention, at the Genomics and Health Impact Blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.